| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.3B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $4.44 | $4.52 | $5.42 | $5.69 | $3.47 | $1.05 | $1.38 | $1.08 |
| EPS (Diluted) | $4.44 | $4.52 | $5.42 | $5.69 | $3.47 | $1.05 | $1.38 | $1.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.9B | $19.4B | $19.3B | $19.3B | $20.4B | $13.2B | $11.4B | $8.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $21.3B | $16.4B | $16.5B | $16.4B | $17.4B | $11.5B | $9.7B | $7.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.6B | $3.0B | $2.9B | $2.9B | $3.0B | $1.7B | $1.7B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.3B | $0.4B | $0.2B | $0.1B | $0.2B | $0.1B |
| Investing Cash Flow | $0.0B | $-0.0B | $-0.2B | $-1.0B | $-0.1B | $-0.5B | $0.0B | $-0.4B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $-0.2B | $-0.2B | $-1.3B | $0.8B | $1.6B | $-0.3B | $0.3B |